Cresset Asset Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1761013
Chicago, IL
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,937,081
+$427,277 QoQ
Shares Held
7,926
+0.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#522
of 1,732 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$120,810
PutShares
300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $108,155,066 across 44 Biotechnology names. VRTX ranks #3 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
736,708 | $52,048,420 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
260,937 | $20,423,538 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
7,926 | $3,937,081 | |
| 4 | EXEL |
Exelixis, Inc.
|
70,918 | $3,858,648 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
102,479 | $3,731,260 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
35,433 | $2,012,948 | |
| 7 | MRNA |
Moderna, Inc.
|
28,359 | $1,985,980 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
11,629 | $1,777,143 |
All Filings in VRTX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,937,081 | 7,926 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,509,804 | 7,860 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,425,134 | 7,555 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,973,330 | 7,592 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $5,443,460 | 12,227 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $6,946,016 | 14,327 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $120,810 | 300 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $6,450,448 | 16,018 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,181,916 | 24,043 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $139,524 | 300 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $46,872 | 100 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $7,517,799 | 16,039 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $984,312 | 2,100 | Put | Defined | 2024-08-14 | |
| 2024-03-31 | $5,030,332 | 12,034 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $2,549,861 | 6,100 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $4,505,492 | 11,073 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $46,318,968 | 133,200 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $3,221,811 | 9,265 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,694,703 | 10,499 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $437,632 | 1,389 | Shares | Sole | 2023-05-12 | |
| 2022-09-30 | $524,646 | 1,812 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $607,821 | 2,157 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $784,736 | 3,007 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $560,858 | 2,554 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $547,616 | 3,019 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $507,502 | 2,517 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $508,214 | 2,365 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $420,685 | 1,780 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $570,635 | 2,097 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $560,878 | 1,932 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $330,750 | 1,390 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||